UP!
| 2016-06-20 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-06-20 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-06-02 | Upgrade | Cantor Fitzgerald | Speculative Buy to Buy | |
| 2016-05-26 | Reiterated Rating | Roth Capital | Buy | $7.50 to $8.00 |
| 2016-05-22 | Reiterated Rating | Oppenheimer | Buy | $10.00 to $13.00 |
| 2016-05-20 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2016-03-24 | Reiterated Rating | Oppenheimer | Buy | $10.00 |
| 2016-02-17 | Lower Price Target | Oppenheimer | Outperform | $18.00 to $10.00 |
| 2016-01-11 | Reiterated Rating | Oppenheimer | Buy | |
| 2015-12-29 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2015-12-23 | Reiterated Rating | Cantor Fitzgerald | Buy | $11.00 |
| 2015-12-09 | Reiterated Rating | Cantor Fitzgerald | Buy | $11.00 |
| 2015-11-13 | Reiterated Rating | Oppenheimer | Outperform | $18.00 |
| 2015-11-03 | Initiated Coverage | Cantor Fitzgerald | Buy | $11.00 |
| 2015-08-20 | Reiterated Rating | Oppenheimer | Outperform | $18.00 |
| 2015-06-30 | Reiterated Rating | Janney Montgomery Scott | Buy | |
| 2015-06-29 | Upgrade | Janney Montgomery Scott | Fair Value | $10.00 to $12.00 |
| 2015-06-12 | Initiated Coverage | Oppenheimer | Outperform | $18.00 |
| 2015-05-06 | Initiated Coverage | Janney Montgomery Scott | Buy | $10.00 |
| 2015-02-17 | Boost Price Target | Roth Capital | Buy | $10.00 to $12.00 |
| 2015-01-06 | Set Price Target | Roth Capital | Buy | $10.00 |
| 2014-09-29 | Lower Price Target | Roth Capital | Buy | $17.00 to $10.00 |
| 2014-01-10 | Boost Price Target | Roth Capital | $17.00 to $18.50 | |
| 2013-10-01 | Initiated Coverage | Roth Capital | Buy | $8.50 |
| 2016-06-20 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-06-20 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-06-02 | Upgrade | Cantor Fitzgerald | Speculative Buy to Buy | |
| 2016-05-26 | Reiterated Rating | Roth Capital | Buy | $7.50 to $8.00 |
| 2016-05-22 | Reiterated Rating | Oppenheimer | Buy | $10.00 to $13.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In TNXP 41 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1.88M |
| MORGAN STANLEY | 0.93M |
| Vanguard Group, Inc | 0.86M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.34M |
| BlackRock Inc. | 0.31M |
| Hudson Bay Capital Management LP | 0.23M |
| TWO SIGMA INVESTMENTS LLC | 0.20M |
| ProShare Advisors LLC | 0.15M |
| Virtu Financial LLC | 0.13M |
| BlackRock Fund Advisors | 58972 |
| NORTHERN TRUST CORP | 50383 |
| STATE STREET CORP | 47627 |
| BlackRock Institutional Trust Company, N.A. | 46543 |
| DIALECTIC CAPITAL MANAGEMENT, LLC | 40000 |
| CITADEL ADVISORS LLC | 26159 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Moss David J PRES, CEO, TRES, CFO, SECR | 30.69% (3250000) | TNXP / |
| DAVIDSON STUART | 14.08% (1490716) | TNXP / |
| DAUGHERTY BRUCE See Remarks | 0.94% (100000) | TNXP / |
| SULLIVAN GREGORY M Chief Medical Officer | 0.41% (43185) | TNXP / |
| MARIO ERNEST | 0.25% (26648) | BSX / CAPN / CELG / CMRX / KIN / TNXP / VVUS / XNPT / |
| LEDERMAN SETH Chief Executive Officer | 0.21% (22700) | TNXP / |
| GERSHELL LELAND CFO and Treasurer | 0.18% (19260) | TNXP / |
| Rhodes John B | 0.08% (8720) | TNXP / |
| LANDRY DONALD W | 0.07% (7710) | SXT / TNXP / |
| SAENGER BRADLEY Chief Financial Officer | 0.06% (6039) | TNXP / |
| Saks Samuel R | 0.04% (3855) | ASPX / DEPO / PDLI / TNXP / |
| MATHER CHARLES E IV | 0.02% (1783) | TNXP / |
| GRACE PATRICK P | 0.01% (1255) | CHE / TNXP / |
UM